198 related articles for article (PubMed ID: 28248819)
1. A Grading System Combining Tumor Budding and Nuclear Diameter Predicts Prognosis in Resected Lung Squamous Cell Carcinoma.
Kadota K; Miyai Y; Katsuki N; Kushida Y; Matsunaga T; Okuda M; Yokomise H; Kanaji N; Bandoh S; Haba R
Am J Surg Pathol; 2017 Jun; 41(6):750-760. PubMed ID: 28248819
[TBL] [Abstract][Full Text] [Related]
2. Comprehensive pathological analyses in lung squamous cell carcinoma: single cell invasion, nuclear diameter, and tumor budding are independent prognostic factors for worse outcomes.
Kadota K; Nitadori J; Woo KM; Sima CS; Finley DJ; Rusch VW; Adusumilli PS; Travis WD
J Thorac Oncol; 2014 Aug; 9(8):1126-39. PubMed ID: 24942260
[TBL] [Abstract][Full Text] [Related]
3. Tumor Spread Through Air Spaces Is an Independent Predictor of Recurrence-free Survival in Patients With Resected Lung Squamous Cell Carcinoma.
Kadota K; Kushida Y; Katsuki N; Ishikawa R; Ibuki E; Motoyama M; Nii K; Yokomise H; Bandoh S; Haba R
Am J Surg Pathol; 2017 Aug; 41(8):1077-1086. PubMed ID: 28498282
[TBL] [Abstract][Full Text] [Related]
4. Clinical significance of E-cadherin, β-catenin, vimentin and S100A4 expression in completely resected squamous cell lung carcinoma.
Zhang H; Liu J; Yue D; Gao L; Wang D; Zhang H; Wang C
J Clin Pathol; 2013 Nov; 66(11):937-45. PubMed ID: 23853314
[TBL] [Abstract][Full Text] [Related]
5. Nuclear grade based on transbronchial cytology is an independent prognostic factor in patients with advanced, unresectable non-small cell lung cancer.
Kadota K; Miyai Y; Katsuki N; Kushida Y; Matsunaga T; Okuda M; Yokomise H; Kanaji N; Bandoh S; Haba R
Cancer Cytopathol; 2016 Sep; 124(9):630-40. PubMed ID: 27177186
[TBL] [Abstract][Full Text] [Related]
6. Independent Validation of Tumor Budding Activity and Cell Nest Size as Determinants of Patient Outcome in Squamous Cell Carcinoma of the Uterine Cervix.
Zare SY; Aisagbonhi O; Hasteh F; Fadare O
Am J Surg Pathol; 2020 Sep; 44(9):1151-1160. PubMed ID: 32452873
[TBL] [Abstract][Full Text] [Related]
7. Proposal of a grading system for squamous cell carcinoma of the lung - the prognostic importance of tumour budding, single cell invasion, and nuclear diameter.
Zombori-Tóth N; Hegedűs F; Almási S; Sejben A; Tiszlavicz L; Furák J; Cserni G; Zombori T
Virchows Arch; 2023 Sep; 483(3):393-404. PubMed ID: 37555982
[TBL] [Abstract][Full Text] [Related]
8. Introducing a novel highly prognostic grading scheme based on tumour budding and cell nest size for squamous cell carcinoma of the uterine cervix.
Jesinghaus M; Strehl J; Boxberg M; Brühl F; Wenzel A; Konukiewitz B; Schlitter AM; Steiger K; Warth A; Schnelzer A; Kiechle M; Beckmann MW; Noske A; Hartmann A; Mehlhorn G; Koch MC; Weichert W
J Pathol Clin Res; 2018 Apr; 4(2):93-102. PubMed ID: 29665323
[TBL] [Abstract][Full Text] [Related]
9. The prognostic value of morphologic findings for lung squamous cell carcinoma patients.
Gürel D; Ulukuş Ç; Karaçam V; Ellidokuz H; Umay C; Öztop İ; Sarıoğlu S
Pathol Res Pract; 2016 Jan; 212(1):1-9. PubMed ID: 26608418
[TBL] [Abstract][Full Text] [Related]
10. Prognostic factors based on clinicopathological data among the patients with resected peripheral squamous cell carcinomas of the lung.
Kinoshita T; Ohtsuka T; Hato T; Goto T; Kamiyama I; Tajima A; Emoto K; Hayashi Y; Kohno M
J Thorac Oncol; 2014 Dec; 9(12):1779-87. PubMed ID: 25226427
[TBL] [Abstract][Full Text] [Related]
11. Tumor budding is an independent prognostic marker in early stage oral squamous cell carcinoma: With special reference to the mode of invasion and worst pattern of invasion.
Shimizu S; Miyazaki A; Sonoda T; Koike K; Ogi K; Kobayashi JI; Kaneko T; Igarashi T; Ueda M; Dehari H; Miyakawa A; Hasegawa T; Hiratsuka H
PLoS One; 2018; 13(4):e0195451. PubMed ID: 29672550
[TBL] [Abstract][Full Text] [Related]
12. Invasion Types Are Associated With Poor Prognosis in Lung Squamous Carcinoma Patients.
Zhao Y; Shen H; Qiu C; Zhang T; Hu P; Qu X; Liu Q; Du J
Medicine (Baltimore); 2015 Oct; 94(43):e1634. PubMed ID: 26512557
[TBL] [Abstract][Full Text] [Related]
13. High postoperative monocyte indicates inferior Clinicopathological characteristics and worse prognosis in lung adenocarcinoma or squamous cell carcinoma after lobectomy.
Hai Y; Chen N; Wu W; Wang Z; Lin F; Guo C; Liu C; Li W; Liu L
BMC Cancer; 2018 Oct; 18(1):1011. PubMed ID: 30348119
[TBL] [Abstract][Full Text] [Related]
14. Lymphovascular invasion in non-small-cell lung cancer: implications for staging and adjuvant therapy.
Higgins KA; Chino JP; Ready N; D'Amico TA; Berry MF; Sporn T; Boyd J; Kelsey CR
J Thorac Oncol; 2012 Jul; 7(7):1141-7. PubMed ID: 22617241
[TBL] [Abstract][Full Text] [Related]
15. Prognostic impact of preoperative tumor marker levels and lymphovascular invasion in pathological stage I adenocarcinoma and squamous cell carcinoma of the lung.
Kinoshita T; Ohtsuka T; Yotsukura M; Asakura K; Goto T; Kamiyama I; Otake S; Tajima A; Emoto K; Hayashi Y; Kohno M
J Thorac Oncol; 2015 Apr; 10(4):619-28. PubMed ID: 25634009
[TBL] [Abstract][Full Text] [Related]
16. A prognostic model of survival in surgically resected squamous cell carcinoma of the lung using clinical, pathologic, and biologic markers.
Bernardi FD; Antonângelo L; Beyruti R; Takagaki T; Saldiva PH; Capelozzi VL
Mod Pathol; 1997 Oct; 10(10):992-1000. PubMed ID: 9346178
[TBL] [Abstract][Full Text] [Related]
17. Tumour budding activity and cell nest size determine patient outcome in oral squamous cell carcinoma: proposal for an adjusted grading system.
Boxberg M; Jesinghaus M; Dorfner C; Mogler C; Drecoll E; Warth A; Steiger K; Bollwein C; Meyer P; Wolff KD; Kolk A; Weichert W
Histopathology; 2017 Jun; 70(7):1125-1137. PubMed ID: 28122134
[TBL] [Abstract][Full Text] [Related]
18. Prognostic impact of lymphovascular invasion compared with that of visceral pleural invasion in patients with pN0 non-small-cell lung cancer and a tumor diameter of 2 cm or smaller.
Tao H; Hayashi T; Sano F; Takahagi A; Tanaka T; Matsuda E; Okabe K
J Surg Res; 2013 Nov; 185(1):250-4. PubMed ID: 23830361
[TBL] [Abstract][Full Text] [Related]
19. Tumor budding is a significant indicator of a poor prognosis in lung squamous cell carcinoma patients.
Masuda R; Kijima H; Imamura N; Aruga N; Nakamura Y; Masuda D; Takeichi H; Kato N; Nakagawa T; Tanaka M; Inokuchi S; Iwazaki M
Mol Med Rep; 2012 Nov; 6(5):937-43. PubMed ID: 22940760
[TBL] [Abstract][Full Text] [Related]
20. Predictive survival markers in patients with surgically resected non-small cell lung carcinoma.
Moldvay J; Scheid P; Wild P; Nabil K; Siat J; Borrelly J; Marie B; Farré G; Labib T; Pottier G; Sesboüé R; Bronner C; Vignaud JM; Martinet Y; Martinet N
Clin Cancer Res; 2000 Mar; 6(3):1125-34. PubMed ID: 10741743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
